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by RFLP analyses of only 1 or 2 loci 
(2,7). Although 5 of the 6 cases of sec-
ondary transmission were linked with 
vOka-associated cases of varicella, 1 
was transmitted from a vaccinee with 
herpes zoster (7). The fact that the sib-
ling reported in that case was already 
vaccinated before varicella developed 
confounds the case.
Postmarketing  surveillance  con-
ducted in Japan by Biken and the gov-
ernmental Relief Systems for Adverse 
Reactions have identified no cases of 
secondary transmission since Biken’s 
vOka was licensed in 1985 (Y.G. and 
N.I., unpub. data). Thus, the case re-
ported here is considered to be rare in 
that vOka was transmitted to a healthy 
susceptible  person  through  close 
contact  with  a  vaccinee  with  herpes 
zoster.
vOka is composed of a mixture 
of genotypically distinct virus strains 
that have 15 base substitutions in gene 
62  compared  with  the  parental  Oka 
strain. Gomi et al. have suggested that 
the amino acid alterations in the gene 
62  products  of  vOka  are  associated 
with the characteristics of vOka, i.e., 
slower growth and less efficient cell-
to-cell  spreading  in  vitro  compared 
with parental Oka (4). Previous stud-
ies have suggested that some alleles 
(positions  107797,  105169,  105356, 
and 108838) in gene 62 were impli-
cated in the formation of vaccine-as-
sociated rash (9,10). The virus in the 
case-patient  reported  here  contained 
1 synonymous nucleotide substitution 
from Biken’s vOka to a wild-type at 
position 105705 in gene 62. Because 
no such alteration was detected in the 
final Biken vOka products, informa-
tion about the in vivo process of natu-
ral selection for the particular genetic 
profile is needed.
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Aichi Virus Strains 
in Children with 
Gastroenteritis, 
China 
To  the  Editor:  Aichi  virus,  a 
member  of  the  Kobuvirus  genus  of 
the Picornaviridae family (1,2), is a 
positive-sense,  single-stranded  RNA 
virus with a genome of 8,280 nt and 
a poly(A) tail. The single, large open-
reading frame (ORF) encodes a poly-
protein of 2,432 aa that is cleaved into 
the typical picornavirus structural pro-
teins (VP0, VP3, VP1) and nonstruc-
tural proteins (2A, 2B, 2C, 3A, 3B, 
3C, 3D) (2,3). Based on the phyloge-
netic analysis of 519-bp sequences at 
the 3C–3D (3 CD) junction, Aichi vi-
ruses can be divided into 2 genotypes, 
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A and B, with ≈90% sequence homol-
ogy (4).
Little is known about the epide-
miology of Aichi virus. Its presence in 
fecal specimens of children having di-
arrhea has been demonstrated in sev-
eral Asian countries (5,6), Brazil and 
Germany (7), France (8), and Tunisia 
(9). Some reports showed a high level 
of  seroprevalence  in  adults  (7,10), 
which suggests widespread exposure 
to Aichi virus during childhood. 
In  the  present  study,  445  fecal 
samples  were  collected  during April 
2008–March 2009 from children 0 to 
6 years of age who were hospitalized 
with acute diarrhea in Shanghai Chil-
dren’s Hospital, People’s Republic of 
China. Ninety-two 2–5-year-old chil-
dren from 3 childcare centers in Shang-
hai City were included as healthy con-
trol  subjects. Viral  nucleic  acid  was 
extracted from 10% stool suspensions 
in phosphate-buffered saline (pH 7.5) 
by QIAamp Viral RNA kit (QIAGEN, 
Hilden,  Germany),  according  to  the 
manufacturer’s instructions. Screening 
for Aichi viruses was done by reverse 
transcription–PCR (RT-PCR) with the 
primers described by Yamashita et al. 
(4), by using a Takara OneStep RT-
PCR kit (TaKaRa, Dalian City, Japan). 
RT-PCR–amplified  DNA  fragments 
of the expected sizes, as determined 
by agarose gel electrophoresis, were 
excised from the gel, extracted, puri-
fied, and sequenced in a 3730 DNA 
Analyzer (Applied Biosystems, Foster 
City, CA, USA). Sequence alignment 
and  phylogenetic  analysis  were  per-
formed by using the ClustalX (http://
bips.u-strasbg.fr/fr/Documentation/
ClustalX)  and  MEGA4  software 
(www.megasoftware.net),  respec-
tively. Aichi virus RNA was detected 
in  8  samples  (1.8%  incidence).  The 
PCR-amplified  products  of  8  strains 
were sequenced, and the resulting se-
quences were submitted to GenBank 
with the strain names Chshc1–8 and 
accession  nos.  FJ890516–FJ890523. 
Sequence analysis, based on the 529-
bp sequences, showed that the isolates 
shared  98.2%–99.6%  identities  with 
each other, which suggests that they 
can  be  considered  a  unique  strain. 
When compared with all Aichi virus 
strains  available  in  GenBank,  the  8 
sequences  shared  91.3%–96.9%  se-
quence identities, except for a strain 
from France, DQ145759, which had 
only 87.2% sequence homology with 
the other strains in this study. Phylo-
genetic analysis of those Aichi virus 
strains, based on the 519-bp sequence, 
showed  that  the  8  strains  belonged 
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Figure. Phylogenetic tree constructed by using the neighbor-joining 
method  and  evaluated  using  the  interior  branch  test  method  with 
MEGA4 software (www.megasoftware.net). Percentage of bootstrap 
support is indicated at each node. GenBank accession number, source, 
and country of origin are indicated. A) Phylogenetic tree constructed 
based on the 519-nt segment in the 3C/D junction region, a genotype 
C Aichi virus strain is included as an outgroup. Phylogenetic trees 
constructed from the capsid gene (B) and complete genome of Aichi 
virus (C); the porcine kobuvirus is included as an outgroup. Scale bars 
indicate nucleotide substitutions per site.LETTERS
to genotype B (Figure, panel A) and 
closely  clustered  with  a  Japanese 
strain AB092830, sharing 96.9% se-
quence identity with it. The 8 Aichi 
virus–positive  samples  were  further 
investigated for norovirus, sapovirus, 
rotavirus,  astrovirus,  and  adenovi-
rus types 40 and 41 by RT-PCR with 
the primers described (9). Results in-
dicated that one of the samples was 
also positive for astrovirus, of which 
the 348-bp–specific fragment was se-
quenced  and  deposited  in  GenBank 
(accession no. GQ292771). No Aichi 
virus was detected in samples from the 
92 healthy control subjects.
The complete genomic sequence 
of strain Chshc7 was then determined 
by using 13 sets of specific oligonu-
cleotide primers designed on the com-
plete genome of 4 Aichi virus strains 
(NC_001918, AB010145, DQ028632, 
AY747174). Results showed that the 
full genome of this virus strain was 
8,244 nt and contained a ORF frame 
with  a  length  of  7,299  nt,  encoding 
a  putative  polyprotein  precursor  of 
2,433 aa. This ORF is preceded by a 5′ 
untranslated region (UTR) at least 712 
nt in length. The 3′ UTR measure 237 
nt, excluding the poly(A) tract. Base 
compositions of the strain were found 
to be A, 19.8%, C, 37.8%, G, 20.9%, 
and  U,  21.5%. The  polyprotein  pre-
cursors of this Aichi strain comprise a 
predicted leader protein of 170 aa and 
putative VP0, VP3, and VP1 proteins 
with lengths of 370 aa, 224 aa, and 278 
aa,  respectively.  Regarding  the  non-
structural proteins, lengths of 111 aa, 
165 aa, and 335 aa are predicted for 
2A, 2B, and 2C, and of 93 aa (29 aa, 
190 aa, 468 aa) for 3A (3B, 3C, 3D).
Phylogenetic  trees  were  con-
structed  on  the  basis  of  the  capsid 
protein gene (Figure, panel B), com-
plete genome sequences of the strain 
Chshc7 (Figure, panel C), and those 
sequences available in GenBank. Both 
phylogenetic  trees  indicated  that  the 
strain  Chsh7  closely  clustered  with 
the Brazilian strain DQ028632, which 
confirmed that Chsh7 belonged to gen-
otype B. Sequence alignment showed 
that  Chsh7  and  the  Brazilian  strain 
(DQ028632) shared 95.3% and 98.1% 
sequence  identities  with  each  other 
over the complete genome and puta-
tive amino acid sequences, respective-
ly, which suggested that the 2 strains 
might  come  from  a  common  ances-
tor. These results will provide useful 
information for further epidemiologic 
study of Aichi virus in China.
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